Ann: Commercial Partnership with Mobvoi for New Health Smartwatch, page-284

Thats all true except that CDX talked up the relationship and their approach to the launch in the last 4C.
Personally I think they over cooked it as in the same release they mentioned a return to profitability late 2022 so it was obviously never going to have a big impact on the bottom line.They would have been better to not show case it as their first new product release if they were not going to follow up with a bit of a PR push on release. For me, its always been abut 2022 and are confident well see better consolidated movement in the share price as we talk about that.